大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/12/09 | 4,425 | 4,507 | 4,420 | 4,466 | +11 | +0.2% | 2,163,700 |
2016/12/08 | 4,513 | 4,519 | 4,428 | 4,455 | -79 | -1.7% | 2,502,800 |
2016/12/07 | 4,517 | 4,543 | 4,475 | 4,534 | +44 | +1% | 1,476,600 |
2016/12/06 | 4,527 | 4,529 | 4,487 | 4,490 | +11 | +0.2% | 950,400 |
2016/12/05 | 4,515 | 4,533 | 4,466 | 4,479 | -39 | -0.9% | 1,007,900 |
2016/12/02 | 4,598 | 4,598 | 4,491 | 4,518 | -56 | -1.2% | 1,701,200 |
2016/12/01 | 4,627 | 4,643 | 4,551 | 4,574 | -73 | -1.6% | 1,882,400 |
2016/11/30 | 4,684 | 4,692 | 4,628 | 4,647 | -30 | -0.6% | 1,851,000 |
2016/11/29 | 4,659 | 4,709 | 4,654 | 4,677 | +16 | +0.3% | 853,300 |
2016/11/28 | 4,640 | 4,670 | 4,630 | 4,661 | ±0 | ±0% | 1,031,300 |
2016/11/25 | 4,674 | 4,692 | 4,645 | 4,661 | -13 | -0.3% | 1,183,200 |
2016/11/24 | 4,778 | 4,778 | 4,665 | 4,674 | -71 | -1.5% | 820,300 |
2016/11/22 | 4,716 | 4,757 | 4,695 | 4,745 | +8 | +0.2% | 703,400 |
2016/11/21 | 4,698 | 4,763 | 4,680 | 4,737 | +40 | +0.9% | 873,000 |
2016/11/18 | 4,759 | 4,773 | 4,677 | 4,697 | -110 | -2.3% | 1,457,200 |
2016/11/17 | 4,775 | 4,828 | 4,750 | 4,807 | +17 | +0.4% | 906,600 |
2016/11/16 | 4,800 | 4,810 | 4,750 | 4,790 | -14 | -0.3% | 1,433,400 |
2016/11/15 | 4,792 | 4,806 | 4,757 | 4,804 | +12 | +0.3% | 1,297,100 |
2016/11/14 | 4,799 | 4,836 | 4,735 | 4,792 | +8 | +0.2% | 1,463,500 |
2016/11/11 | 4,709 | 4,820 | 4,655 | 4,784 | +78 | +1.7% | 1,839,900 |
2016/11/10 | 4,646 | 4,708 | 4,585 | 4,706 | +260 | +5.8% | 1,485,200 |
2016/11/09 | 4,550 | 4,610 | 4,405 | 4,446 | -52 | -1.2% | 1,333,400 |
2016/11/08 | 4,504 | 4,525 | 4,493 | 4,498 | -44 | -1% | 796,700 |
2016/11/07 | 4,560 | 4,572 | 4,493 | 4,542 | +59 | +1.3% | 906,400 |
2016/11/04 | 4,566 | 4,577 | 4,450 | 4,483 | -95 | -2.1% | 1,186,000 |
2016/11/02 | 4,600 | 4,612 | 4,544 | 4,578 | -28 | -0.6% | 766,900 |
2016/11/01 | 4,571 | 4,625 | 4,560 | 4,606 | +9 | +0.2% | 760,200 |
2016/10/31 | 4,565 | 4,605 | 4,545 | 4,597 | -9 | -0.2% | 1,173,300 |
2016/10/28 | 4,627 | 4,635 | 4,586 | 4,606 | -2 | ±0% | 1,083,200 |
2016/10/27 | 4,590 | 4,615 | 4,582 | 4,608 | -1 | ±0% | 696,600 |
2016/10/26 | 4,558 | 4,610 | 4,551 | 4,609 | +60 | +1.3% | 964,700 |
2016/10/25 | 4,528 | 4,557 | 4,513 | 4,549 | +15 | +0.3% | 914,300 |
2016/10/24 | 4,499 | 4,546 | 4,496 | 4,534 | +29 | +0.6% | 779,800 |
2016/10/21 | 4,568 | 4,586 | 4,505 | 4,505 | -78 | -1.7% | 1,107,200 |
2016/10/20 | 4,641 | 4,656 | 4,560 | 4,583 | -91 | -1.9% | 1,365,200 |
2016/10/19 | 4,681 | 4,713 | 4,658 | 4,674 | -8 | -0.2% | 1,044,600 |
2016/10/18 | 4,625 | 4,706 | 4,625 | 4,682 | +59 | +1.3% | 1,147,600 |
2016/10/17 | 4,603 | 4,650 | 4,597 | 4,623 | -2 | ±0% | 1,024,000 |
2016/10/14 | 4,633 | 4,680 | 4,603 | 4,625 | +11 | +0.2% | 1,203,900 |
2016/10/13 | 4,591 | 4,617 | 4,569 | 4,614 | +41 | +0.9% | 980,000 |
2016/10/12 | 4,583 | 4,638 | 4,568 | 4,573 | -53 | -1.1% | 1,244,900 |
2016/10/11 | 4,670 | 4,695 | 4,594 | 4,626 | +77 | +1.7% | 1,055,800 |
2016/10/07 | 4,555 | 4,576 | 4,524 | 4,549 | -11 | -0.2% | 646,000 |
2016/10/06 | 4,581 | 4,581 | 4,541 | 4,560 | -21 | -0.5% | 883,200 |
2016/10/05 | 4,574 | 4,599 | 4,539 | 4,581 | +15 | +0.3% | 930,500 |
2016/10/04 | 4,597 | 4,612 | 4,548 | 4,566 | -34 | -0.7% | 1,226,600 |
2016/10/03 | 4,600 | 4,638 | 4,588 | 4,600 | +11 | +0.2% | 972,400 |
2016/09/30 | 4,520 | 4,628 | 4,509 | 4,589 | -41 | -0.9% | 1,195,400 |
2016/09/29 | 4,653 | 4,662 | 4,582 | 4,630 | +12 | +0.3% | 806,800 |
2016/09/28 | 4,600 | 4,651 | 4,575 | 4,618 | -60 | -1.3% | 1,211,100 |
2051~
2100
件表示中 / 3518件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム